154 related articles for article (PubMed ID: 35091007)
1. Dermal and transdermal peptide delivery using enhancer molecules and colloidal carrier systems. Part V: Transdermal administration of insulin.
Alyoussef Alkrad J; Neubert RHH
Int J Pharm; 2022 Mar; 616():121511. PubMed ID: 35091007
[TBL] [Abstract][Full Text] [Related]
2. Dermal and Transdermal Macromolecule Delivery Using Enhancer Molecules and Colloidal Carrier Systems - Part 2: Percutaneous Administration of Heparin.
Alyoussef Alkrad J; Almalki YA; Dahmash EZ; Hassouneh LK; Neubert RHH
Skin Pharmacol Physiol; 2023; 36(1):16-26. PubMed ID: 36455520
[TBL] [Abstract][Full Text] [Related]
3. Dermal peptide delivery using enhancer molecules and colloidal carrier systems. Part III: Tetrapeptide GEKG.
Sommer E; Neubert RHH; Mentel M; Tuchscherer B; Mrestani Y; Wohlrab J
Eur J Pharm Sci; 2018 Nov; 124():137-144. PubMed ID: 30165235
[TBL] [Abstract][Full Text] [Related]
4. Dermal peptide delivery using enhancer moleculs and colloidal carrier systems. Part II: Tetrapeptide PKEK.
Neubert RHH; Sommer E; Schölzel M; Tuchscherer B; Mrestani Y; Wohlrab J
Eur J Pharm Biopharm; 2018 Mar; 124():28-33. PubMed ID: 29247690
[TBL] [Abstract][Full Text] [Related]
5. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro transdermal availability of Ibuprofen using novel solubility enhancing fluid nanosized carrier systems.
Alyoussef Alkrad J; Sayeh WN; Sijari A; Naser A; Neubert RHH; Dahmash EZ
Int J Pharm; 2024 Jan; 650():123684. PubMed ID: 38070659
[TBL] [Abstract][Full Text] [Related]
7. Oleic acid-reinforced PEGylated polymethacrylate transdermal film with enhanced antidyslipidemic activity and bioavailability of atorvastatin: A mechanistic ex-vivo/in-vivo analysis.
El-Say KM; Ahmed TA; Aljefri AH; El-Sawy HS; Fassihi R; Abou-Gharbia M
Int J Pharm; 2021 Oct; 608():121057. PubMed ID: 34461173
[TBL] [Abstract][Full Text] [Related]
8. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
9. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes.
Jain SK; Gupta Y; Jain A; Rai K
Drug Deliv; 2008; 15(3):141-7. PubMed ID: 18379926
[TBL] [Abstract][Full Text] [Related]
10. Hydroxypropyl-β-cyclodextrin grafted polyethyleneimine used as transdermal penetration enhancer of diclofenac sodium.
Yan Y; Xing J; Xu W; Zhao G; Dong K; Zhang L; Wang K
Int J Pharm; 2014 Oct; 474(1-2):182-92. PubMed ID: 25138253
[TBL] [Abstract][Full Text] [Related]
11. Perspectives of Lipid-Based Drug Carrier Systems for Transdermal Delivery.
Pradhan M; Srivastava S; Singh D; Saraf S; Saraf S; Singh MR
Crit Rev Ther Drug Carrier Syst; 2018; 35(4):331-367. PubMed ID: 29972681
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
13. High-efficient nano-carrier gel systems for testosterone propionate skin delivery.
Meng S; Chen Z; Yang L; Zhang X; Guo J; Li M; Li J
Pharm Dev Technol; 2015; 20(6):724-9. PubMed ID: 24799076
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis.
Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC
AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397
[TBL] [Abstract][Full Text] [Related]
15. Systemic enhancement of papaverine transdermal gel for erectile dysfunction.
Wen MM; El-Kamel AH; Khalil SA
Drug Dev Ind Pharm; 2012 Aug; 38(8):912-22. PubMed ID: 22080854
[TBL] [Abstract][Full Text] [Related]
16. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
Panchagnula R; Bokalial R; Sharma P; Khandavilli S
Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
[TBL] [Abstract][Full Text] [Related]
18. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
[TBL] [Abstract][Full Text] [Related]
19. Formulation study of a patch containing propranolol by design of experiments.
Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
[TBL] [Abstract][Full Text] [Related]
20. Dermal and transdermal delivery of pharmaceutically relevant macromolecules.
Münch S; Wohlrab J; Neubert RHH
Eur J Pharm Biopharm; 2017 Oct; 119():235-242. PubMed ID: 28647443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
